RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation

Cancer Letters

Volumn 306, Issue 2, 2011, Pages 180-189

  Walsh, Naomi ^a   Larkin, AnneMarie ^a   Swan, Niall ^b,c   Conlon, Kevin ^b   Dowling, Paul ^a   McDermott, Ray ^b   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Hop STIP1 STI1 (Hsp70 Hsp90 organising protein); Immunohistochemistry; In vitro invasion; MMP 2; Pancreatic cancer

Indexed keywords

BCR ABL PROTEIN; CHAPERONE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE A; HEAT SHOCK PROTEIN 70 HEAT SHOCK PROTEIN 90 ORGANIZING PROTEIN; HEAT SHOCK PROTEIN 90; PROTEIN KINASE P60; SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MMP2 GENE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ADENOCARCINOMA, MUCINOUS; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CELL ADHESION; CELL MOVEMENT; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MATRIX METALLOPROTEINASE 2; MOLECULAR CHAPERONES; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 79955478704     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.03.004     Document Type: Article

References (43)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2007, 57:43-66.
2. Brennan M.F. Adjuvant therapy following resection for pancreatic adenocarcinoma. Surg. Oncol. Clin. N. Am. 2004, 13:555-566. vii.
3. Carrigan P.E., Sikkink L.A., Smith D.F., Ramirez-Alvarado M. Domain: domain interactions within hop, the Hsp70/Hsp90 organizing protein, are required for protein stability and structure. Protein Sci. 2006, 15:522-532.
4. Chen S., Smith D.F. Hop as an adaptor in the heat shock protein 70 (Hsp70) and hsp90 chaperone machinery. J. Biol. Chem. 1998, 273:35194-35200.
5. Hernandez M.P., Sullivan W.P., Toft D.O. The assembly and intermolecular properties of the hsp70-Hop-hsp90 molecular chaperone complex. J. Biol. Chem. 2002, 277:38294-38304.
6. Wegele H., Muller L., Buchner J. Hsp70 and Hsp90 - a relay team for protein folding. Rev. Physiol. Biochem. Pharmacol. 2004, 151:1-44.
7. Kubota H., Yamamoto S., Itoh E., et al. Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperones. 2010, 15:1003-1011.
8. Sun W., Xing B., Sun Y., et al. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol. Cell. Proteomics. 2007, 6:1798-1808.
9. Erlich R.B., Kahn S.A., Lima F.R., Muras A.G., Martins R.A., Linden R., Chiarini L.B., Martins V.R., Moura Neto V. STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 2007, 55:1690-1698.
10. Bredemeyer A.J., Carrigan P.E., Fehniger T.A., Smith D.F., Ley T.J. Hop cleavage and function in granzyme B-induced apoptosis. J. Biol. Chem. 2006, 281:37130-37141.
11. Pick E., Kluger Y., Giltnane J.M., Moeder C., Camp R.L., Rimm D.L., Kluger H.M. High HSP90 expression is associated with decreased survival in breast cancer. Cancer Res. 2007, 67:2932-2937.
12. Ogata M., Naito Z., Tanaka S., Moriyama Y., Asano G. Overexpression and localization of heat shock proteins mRNA in pancreatic carcinoma. J. Nippon Med. Sch. 2000, 67:177-185.
13. Aghdassi A., Phillips P., Dudeja V., Dhaulakhandi D., Sharif R., Dawra R., Lerch M.M., Saluja A. Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res. 2007, 67:616-625.
14. Lindquist S. The heat-shock response. Annu. Rev. Biochem. 1986, 55:1151-1191.
15. Fuqua S.A., Oesterreich S., Hilsenbeck S.G., Von Hoff D.D., Eckardt J., Osborne C.K. Heat shock proteins and drug resistance. Breast Cancer Res. Treat. 1994, 32:67-71.
16. Powers M.V., Workman P. Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors. Endocr. Relat. Cancer. 2006, 13(Suppl. 1):S125-35.
17. Walsh N., O'Donovan N., Kennedy S., Henry M., Meleady P., Clynes M., Dowling P. Identification of pancreatic cancer invasion-related proteins by proteomic analysis. Proteome Sci. 2009, 7:3.
18. Walsh N., Clynes M., Crown J., O'Donovan N. Alterations in integrin expression modulates invasion of pancreatic cancer cells. J. Exp. Clin. Cancer Res. 2009, 28:140.
19. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987, 47:3239-3245.
20. Eustace B.K., Sakurai T., Stewart J.K., et al. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat. Cell Biol. 2004, 6:507-514.
21. Eustace B.K., Jay D.G. Extracellular roles for the molecular chaperone, hsp90. Cell Cycle 2004, 3:1098-1100.
22. Tsutsumi S., Scroggins B., Koga F., Lee M.J., Trepel J., Felts S., Carreras C., Neckers L. A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene 2008, 27:2478-2487.
23. Stellas D., Karameris A., Patsavoudi E. Monoclonal antibody 4C5 immunostains human melanomas and inhibits melanoma cell invasion and metastasis. Clin. Cancer Res. 2007, 13:1831-1838.
24. Kim M.S., Kwak H.J., Lee J.W., et al. 17-Allylamino-17-demethoxygeldanamycin down-regulates hyaluronic acid-induced glioma invasion by blocking matrix metalloproteinase-9 secretion. Mol. Cancer. Res. 2008, 6:1657-1665.
25. Kleiner D.E., Stetler-Stevenson W.G. Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol. 1999, 43:S42-51. Suppl.
26. Foda H.D., Zucker S. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov. Today 2001, 6:478-482.
27. Gress T.M., Muller-Pillasch F., Lerch M.M., Friess H., Buchler M., Adler G. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int. J. Cancer 1995, 62:407-413.
28. Gress T.M., Muller-Pillasch F., Weber C., Lerch M.M., Friess H., Buchler M., Beger H.G., Adler G. Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res. 1994, 54:547-551.
29. Ferrarini M., Heltai S., Zocchi M.R., Rugarli C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int. J. Cancer 1992, 51:613-619.
30. Brown M.A., Zhu L., Schmidt C., Tucker P.W. Hsp90-from signal transduction to cell transformation. Biochem. Biophys. Res. Commun. 2007, 363:241-246.
31. Kamal A., Thao L., Sensintaffar J., Zhang L., Boehm M.F., Fritz L.C., Burrows F.J. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003, 425:407-410.
32. Birchmeier C., Birchmeier W., Gherardi E., Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 2003, 4:915-925.
33. Wang S., Pashtan I., Tsutsumi S., Xu W., Neckers L. Cancer cells harboring MET gene amplification activate alternative signaling pathways to escape MET inhibition but remain sensitive to Hsp90 inhibitors. Cell Cycle 2009, 8:2050-2056.
34. Webb C.P., Hose C.D., Koochekpour S., Jeffers M., Oskarsson M., Sausville E., Monks A., Vande Woude G.F. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network. Cancer Res. 2000, 60:342-349.
35. Sidera K., Gaitanou M., Stellas D., Matsas R., Patsavoudi E. A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. J. Biol. Chem. 2008, 283:2031-2041.
36. Sidera K., Patsavoudi E. Extracellular HSP90: conquering the cell surface. Cell Cycle 2008, 7:1564-1568.
37. Lima F.R., Arantes C.P., Muras A.G., Nomizo R., Brentani R.R., Martins V.R. Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J. Neurochem. 2007, 103:2164-2176.
38. Honore B., Leffers H., Madsen P., Rasmussen H.H., Vandekerckhove J., Celis J.E. Molecular cloning and expression of a transformation-sensitive human protein containing the TPR motif and sharing identity to the stress-inducible yeast protein STI1. J. Biol. Chem. 1992, 267:8485-8491.
39. Zanata S.M., Lopes M.H., Mercadante A.F., et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 2002, 21:3307-3316.
40. Longshaw V.M., Chapple J.P., Balda M.S., Cheetham M.E., Blatch G.L. Nuclear translocation of the Hsp70/Hsp90 organizing protein mSTI1 is regulated by cell cycle kinases. J. Cell Sci. 2004, 117:701-710.
41. Daniel S., Bradley G., Longshaw V.M., Soti C., Csermely P., Blatch G.L. Nuclear translocation of the phosphoprotein hop (Hsp70/Hsp90 organizing protein) occurs under heat shock and its proposed nuclear localization signal is involved in Hsp90 binding. Biochim. Biophys. Acta 2008, 1783:1003-1014.
42. Longshaw V.M., Baxter M., Prewitz M., Blatch G.L. Knockdown of the co-chaperone eu promotes extranuclear accumulation of Stat3 in mouse embryonic stem cells. Eur. J. Cell Biol. 2009, 88:153-166.
43. Horibe T., Kohno M., Haramoto M., Ohara K., Kawakami K. Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent. J. Trans. Med. 2011, 9:8.